User menu

Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

Bibliographic reference Poujol-Robert, Armelle ; Boëlle, Pierre-Yves ; Wendum, Dominique ; Poupon, Raoul ; Robert, Annie. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.. In: Digestive diseases and sciences, Vol. 51, no. 9, p. 1633-6 (2006)
Permanent URL http://hdl.handle.net/2078.1/25822
  1. Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36 (Suppl 1):S35–46
  2. Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ (2003) Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52:404–409
  3. Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A (2004) Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol 99:527–531
  4. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, Apple R, Cheng S, Thomas H, Thursz M (2003) Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 52:1206–1210
  5. Poujol-Robert A, Boëlle PY, Poupon R, Robert A (2004) Activated protein C resistance (factor V Leiden) as a risk factor for cirrhosis in chronic hepatitis C patients. Hepatology 39:1174–1175
  6. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J (1969) Venous thromboembolic disease and ABO blood group type. A cooperative study. Lancet 1:539–542
  7. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–154
  8. Robert A, Aillaud MF, Eschwege V, Randrianjohany A, Scarabin Y, Juhan-Vague I (2000) ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemostasis 83:630–631
  9. The French Metavir Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15–20
  10. Agresti A (1996) An introduction to categorical data analysis. John Wiley & Sons, New York
  11. Harrell Frank E., Regression Modeling Strategies, ISBN:9781441929181, 10.1007/978-1-4757-3462-1
  12. Anstee QM, Wright M, Goldin R,et al. (2004) The factor V Leiden mutation accelerates disease progression in a mouse model of hepatic fibrosis induced by chronic carbon tetrachloride exposure. Hepatology 40;534A
  13. Marra F, Grandaliano G, Valente AJ, Abboud HE (1995) Thrombin stimulates proliferation of liver fat-storing cells and expression of monocytes chemotactic protein-1: potential role in liver injury. Hepatology 22:780–787
  14. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G (1995) Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. Hepatology 21:1238–1247
  15. Goodman ZD, Ishak KG (1982) Occlusive venous lesions in alcoholic liver disease. Gastroenterology 83:786–796
  16. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695
  17. Kraaijenhagen RA, in’t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83:5–9
  18. Kamphuisen P. W., Eikenboom J. C. J., Bertina R. M., Elevated Factor VIII Levels and the Risk of Thrombosis, 10.1161/01.atv.21.5.731